EUVIMEDEUVIMED entdecken
Crossref

Probiotics as a Promising Strategy for Preventing Urinary Tract Infections: Mechanisms, Efficacy, and Clinical Evidence

Temiyefunolu Akuchukwu Ngwu, Oluwaseun Oyetunji Olasunkanmi, Victor Akpe, Ian Edwin Cock

Pharmacognosy Communications · 17.07.2026 · 16 (3) · 137-150

DOI: 10.5530/pc.2026.3.16 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacognosy Communications, online erschienen am 17.07.2026. Verfasst von Temiyefunolu Akuchukwu Ngwu und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urinary tract infections (UTIs) remain one of the most prevalent bacterial infections globally, with Escherichia coli accounting for most cases and women disproportionately affected due to anatomical and hormonal factors. Recurrent UTIs, which occur in up to 25% of initially affected women, continue

Zitieren

APA

Ngwu, T. A., Olasunkanmi, O. O., Akpe, V., & Cock, I. E. (2026). Probiotics as a Promising Strategy for Preventing Urinary Tract Infections: Mechanisms, Efficacy, and Clinical Evidence. Pharmacognosy Communications, 16(3), 137-150. https://doi.org/10.5530/pc.2026.3.16

Vancouver

Ngwu TA, Olasunkanmi OO, Akpe V, Cock IE. Probiotics as a Promising Strategy for Preventing Urinary Tract Infections: Mechanisms, Efficacy, and Clinical Evidence. Pharmacognosy Communications. 2026;16(3):137-150. doi:10.5530/pc.2026.3.16

BibTeX
@article{Ngwu2026,
  author = {Ngwu, Temiyefunolu Akuchukwu and Olasunkanmi, Oluwaseun Oyetunji and Akpe, Victor and Cock, Ian Edwin},
  title = {Probiotics as a Promising Strategy for Preventing Urinary Tract Infections: Mechanisms, Efficacy, and Clinical Evidence},
  journal = {Pharmacognosy Communications},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {137--150},
  doi = {10.5530/pc.2026.3.16}
}
Kostenlos starten →